与甲铁酸相关的不良药物反应:使用FAERS数据库从2004年到2024年的真实世界药监测研究
Siyu Liu1, Zhang Yuan1, Shicong Rao1
1Longyan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Frontiers in immunology
|June 19, 2025
概括
这项研究分析了130,818份梅托雷克萨特不良事件报告,发现免疫系统障碍和药物过敏是显著的风险,特别是在老年患者中. 加强监测对于安全使用甲索特来说至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 药品安全 药品安全
背景情况:
- 甲基 (MTX) 是广泛使用的,但需要全面的安全分析.
- 了解MTX不良反应 (AE) 和影响因素对于临床实践至关重要.
研究的目的:
- 分析在临床使用中甲索的安全性.
- 为了确定AE的发病率和相关的影响因素.
- 提供证据,证明安全的甲索特雷克萨特药物治疗实践.
主要方法:
- 利用了FDA不良事件报告系统 (FAERS) 的数据 (2004-2024年).
- 在AE信号检测中使用了ROR,PRR,BCPNN和MGPS等统计方法.
- 根据性别,年龄和报告员类别进行了子组分析.
主要成果:
- 分析了130,818份与MTX相关的AE报告.
- 免疫系统障碍显示出最强的信号 (ROR=2.35),老年女性药物过敏风险增加 (ROR=7.91).
- 消费者和医疗保健专业人员报告的优先事项不同,强调"药物无效"和"疼痛"作为共同关注点.
结论:
- 确认已知的MTXAE,并识别潜在的新AE.
- 建议加强基于患者因素 (性别,年龄) 的监测,特别是针对老年人免疫相关的副作用.
- 表明MTX副作用的范围可能比以前认可的更广泛,需要进一步研究.
相关概念视频
Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Phase II Reactions: Methylation Reactions
370
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
370
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K


